Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
Budget & You Live : Real-Time Analysis Of All The FM’s Big Announcements
Budget 2023
Budget 2023
you are here: HomeNewsBusiness

COVID vaccine maker AstraZeneca sees profit slump

Profit after tax slumped to $386 million (366 million euros), AstraZeneca said in a statement.

April 29, 2022 / 01:36 PM IST
Representative image.

Representative image.

British COVID vaccine maker AstraZeneca on Friday announced a 75-percent slide in first-quarter net profit on higher costs linked to its takeover of US biotech firm Alexion.

Profit after tax slumped to $386 million (366 million euros), AstraZeneca said in a statement.

Revenue however surged 56 percent to $11.39 billion, helped by sales of Alexion medicines plus AstraZeneca's COVID-19 vaccine and other drugs.

But the UK group has faced vast costs following its $39-billion takeover of Alexion.